- Publications
- Influence
Share This Author
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
- G. Raimondo, J. Allain, F. Zoulim
- BiologyJournal of hepatology
- 1 October 2008
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
- P. Simmonds, J. Bukh, A. Widell
- BiologyHepatology
- 1 October 2005
TLDR
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.
- C. Hézode, N. Forestier, S. Zeuzem
- MedicineThe New England journal of medicine
- 10 December 2009
TLDR
An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection…
- B. Bartosch, Géraldine Verney, F. Cosset
- Biology, MedicineJournal of Virology
- 1 July 2005
TLDR
Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens.
- J. Pawlotsky
- Medicine, BiologyGastroenterology
- 1 July 2016
TLDR
Antiviral drug‐resistant HBV: Standardization of nomenclature and assays and recommendations for management
TLDR
Structural biology of hepatitis C virus
- F. Penin, J. Dubuisson, F. Rey, D. Moradpour, J. Pawlotsky
- Biology, MedicineClinics in liver disease
- 1 January 2004
TLDR
Structural biology of hepatitis C virus.
- F. Penin, J. Dubuisson, F. Rey, D. Moradpour, J. Pawlotsky
- Biology, MedicineHepatology
- 1 February 2003
EASL Recommendations on Treatment of Hepatitis C 2016.
- J. Pawlotsky, A. Aghemo, G. Dusheiko, X. Forns, M. Puoti, C. Sarrazin
- MedicineJournal of hepatology
- 2017
Treatment failure and resistance with direct‐acting antiviral drugs against hepatitis C virus
- J. Pawlotsky
- Medicine, BiologyHepatology
- 1 May 2011
Current treatment of chronic hepatitis C virus (HCV) infection is based on the combination of pegylated interferon‐α and ribavirin. The recent development of direct‐acting antiviral (DAA) molecules…
...
...